PharmTech's 40th Anniversary

Jul 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Russell Madsen, president, The Williamsburg Group, and member of the Pharmaceutical Technology editorial advisory board, shares his thoughts on technology innovations and regulatory implications.
Jul 02, 2017
Pharmaceutical Technology
The more pharma science and technology change, the more business and policy concerns stay the same.
Jul 02, 2017
Pharmaceutical Technology
Pharmaceutical Technology marks 40 years covering the bio/pharma industry.
Jul 02, 2017
Pharmaceutical Technology
As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.
Jul 02, 2017
Pharmaceutical Technology
How has the bio/pharmaceutical contract manufacturing industry evolved over the years and what does the future hold?
Jul 02, 2017
Pharmaceutical Technology
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
Jul 02, 2017
Pharmaceutical Technology
New ADC therapies must overcome manufacturing challenges to reach market.
Jul 02, 2017
Pharmaceutical Technology
Real-time alternatives to dissolution testing are required for continuous manufacturing to reach mainstream use.
Jul 02, 2017
Pharmaceutical Technology
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
Jul 02, 2017
Pharmaceutical Technology
Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.
native1_300x100
lorem ipsum